Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss, net of tax	Unearned ESOP Shares
Balances at beginning of period (in shares) at Dec. 31, 2021	9,125,759
Balances at beginning of period at Dec. 31, 2021	$ 157,879		$ 91	$ 72,298	$ 86,162		$ 174	$ (846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,260				3,260
Other comprehensive income (loss), net of tax	$ (2,063)						(2,063)
Exercise of stock options (in shares)	2,000
Exercise of stock options	$ 21			21
Issuance of common stock - restricted stock awards, net (in shares)	34,210
Issuance of common stock - restricted stock awards, net	$ 0		0
Compensation related to stock options and restricted stock awards	188			188
Allocation of ESOP shares	$ 475			193				282
Repurchase and retirement of common stock (in shares)	(40,784)
Repurchase and retirement of common stock	$ (694)		0	(694)
Canceled common stock - restricted stock awards (in shares)	(13,208)
Canceled common stock - restricted stock awards	$ (226)			(226)
Cash dividend declared and paid	$ (1,083)				(1,083)
Balances at end of period (in shares) at Mar. 31, 2022	9,107,977
Balances at end of period at Mar. 31, 2022	$ 157,757		91	71,780	88,339		(1,889)	(564)
Balances at beginning of period (in shares) at Dec. 31, 2022	9,127,595
Balances at beginning of period at Dec. 31, 2022	$ 160,360	$ (395)	91	72,424	95,059	$ 395	(7,214)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,122				2,122
Other comprehensive income (loss), net of tax	$ (1,275)						(1,275)
Exercise of stock options (in shares)	0
Issuance of common stock - restricted stock awards, net (in shares)	27,618
Issuance of common stock - restricted stock awards, net	$ 1		1	0
Compensation related to stock options and restricted stock awards	$ 128			128
Canceled common stock - restricted stock awards (in shares)	(7,127)
Canceled common stock - restricted stock awards	$ (107)			(107)
Cash dividend declared and paid	$ (1,189)				(1,189)
Balances at end of period (in shares) at Mar. 31, 2023	9,148,086
Balances at end of period at Mar. 31, 2023	$ 159,645		$ 92	$ 72,445	$ 95,597		$ (8,489)	$ 0